Novel uses for anti-platelet agents as anti-inflammatory drugs.
about
Platelets in inflammation: regulation of leukocyte activities and vascular repairClopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness.Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.IL-17A increases ADP-induced platelet aggregation.Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthmaAirway platelet activation is associated with airway eosinophilic inflammation in asthmaFactors associated with change in exacerbation frequency in COPDPlatelets miRNA as a Prediction Marker of Thrombotic EpisodesAnti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity.Atorvastatin and clopidogrel interfere with photosensitization in vitro.beta-glucan from Saccharomyces cerevisiae as a blood platelet antioxidant.Pro-inflammatory role of platelets in hypertension-mediated end-organ damage : Editorial to: "Inhibition of Platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis" by L.-X. Jia et al.Platelets stimulate airway smooth muscle cell proliferation through mechanisms involving 5-lipoxygenase and reactive oxygen species.A novel inflammatory role for platelets in sickle cell disease.Platelet membranes induce airway smooth muscle cell proliferation.Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).
P2860
Q26852677-308FC23C-2278-4E7D-92AB-6C56F485E7C0Q30415074-D723C27B-B951-46F6-A421-78AD0DF5ACD9Q33685876-3F6D217C-95A2-4F99-BF48-0A9B95488604Q35238914-65096466-FEDC-4D5D-A800-E2FD7B8EDFFBQ35813671-16F3C96A-C95B-4E31-AA53-A16E9F35BEB7Q35884726-24CA8EA0-A225-41E5-BE06-71DCF90D5FB4Q37071132-53AD729B-61AD-4099-8A18-EDB4F938190BQ39064325-2CC794A1-00D9-4029-90EB-DA1A245EF4A4Q39258164-32D35450-6CFB-4D05-8EED-4E23A300B61EQ39508495-2BDB7640-6BF0-4D6D-9634-58BC35B16439Q43072124-FE5AB02B-830A-42D1-A00E-61716CED954DQ45729733-BD5C944C-FCD0-4CDE-BF92-DC5BCE21FCB8Q46268340-3F96DE64-95F8-4BFE-88AC-C4FB978221BFQ52979449-E220229A-D374-4345-A147-E7F966D14DC6Q53278946-FC26978A-0DF5-4C1E-8E6B-F158156AEDAAQ54949062-6D777096-3416-4C84-921D-3899EB2C287F
P2860
Novel uses for anti-platelet agents as anti-inflammatory drugs.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Novel uses for anti-platelet agents as anti-inflammatory drugs.
@ast
Novel uses for anti-platelet agents as anti-inflammatory drugs.
@en
type
label
Novel uses for anti-platelet agents as anti-inflammatory drugs.
@ast
Novel uses for anti-platelet agents as anti-inflammatory drugs.
@en
prefLabel
Novel uses for anti-platelet agents as anti-inflammatory drugs.
@ast
Novel uses for anti-platelet agents as anti-inflammatory drugs.
@en
P2860
P356
P1476
Novel uses for anti-platelet agents as anti-inflammatory drugs
@en
P2093
S C Pitchford
P2860
P304
P356
10.1038/SJ.BJP.0707364
P407
P577
2007-07-02T00:00:00Z